Literature DB >> 21269590

Unusual acute promyelocytic leukemia following de novo renal transplant: case report and literature review.

C-P Lai1, C-C Chang, C-Y Chung, M-L Chen.   

Abstract

Acute promyelocytic leukemia (APL) with transcripting three isoforms of mRNA from PML-RAR alpha fusion genes following renal transplantation has never been reported in the literature. A 39-year-old man received a cadaveric renal allograft for IgA chronic kidney disease in 2006 and was consecutively immunosuppressed by tacrolimus, mycophenolate mofetil, and prednisolone. In 2008, he presented with gum bleeding and weight loss. Following bone marrow biopsy, we diagnosed acute promyelocytic leukemia. Molecular analysis demonstrated atypical presence consisting of three isoforms of mRNA from PML-RAR alpha fusion genes. The patient was administered with three courses of consolidation chemotherapy plus atretinoin, resulting in complete remission and did not jeopardize his allograft function. This novel finding suggests that the leukemogenesis of APL may be polyclonal, sharing similar progenitor targeting on complicated karyotypes, responding well to current chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269590     DOI: 10.5414/cn106521

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Clinical and pathologic features of secondary acute promyelocytic leukemia.

Authors:  Amy S Duffield; Joseph Aoki; Mark Levis; Kathleen Cowan; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Milena Vuica-Ross
Journal:  Am J Clin Pathol       Date:  2012-03       Impact factor: 2.493

2.  Acute promyelocytic leukemia after renal transplant and filgrastim treatment for neutropenia.

Authors:  Jaime A Campbell; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-10

3.  Kidney transplantation in a patient with end stage renal disease after complete remission of acute promyelocytic leukemia.

Authors:  Hyun Ji Chun; Su Jeong Kim; In O Sun; Byung Ha Chung; Ji-Il Kim; In Sung Moon; Woo-Sung Min; Chul Woo Yang
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.